LRRK2 and Parkinson disease: To test the effect of Rab38 on PD-mutant LRRK2, Rab38 knockdown (Fig. S1G) was performed in B16 cells expressing exogenous WT, G2019S, or R1441G GFP-LRRK2 (Fig. 1E).